— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected.
— Net sales remained flat at $70 million, vs. $71.2 million expected.
— US net sales grew 1.8% to $55.6 million.
— International net sales increased 5.6% to $14.4 million.
— Oncology net sales rose 5.1% to $16.1 million.
— Vascular Interventions and Therapies net sales grew 0.6% to $31.2 million.
— Vascular Access net sales fell 4% to $22.8 million.
— FY2020 net sales are expected to be $280-286 million.
— FY2020 adjusted EPS is expected to be $0.10-0.15.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
